Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Depreciation" stands at 25.03 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Kyowa Kirin Co Ltd's second quarter result of 6.22 Billion JPY for the item "Depreciation" represents an increase of 1.93 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 6.22 Billion JPY for the item "Depreciation" represents a decrease of -3.77 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 25.03 Billion JPY for the item "Depreciation" represents a decrease of -0.97 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 7.39 percent compared to the value the year prior.
The 1 year change in percent is 7.39.
The 3 year change in percent is 27.13.
The 5 year change in percent is 38.82.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Depreciation | 905,699,262,464.00 |
![]() | Johnson & Johnson - Depreciation | 486,508,953,600.00 |
![]() | AbbVie Inc - Depreciation | 399,570,305,024.00 |
![]() | Roche Holding AG - Depreciation | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Depreciation | 280,205,508,085.11 |